Federal contract award
15B50525F00000191
OPSUMIT 10MG-QTY 4 @ $6,270.03 ADEMPAS 1MG, QTY 1 @ $12,153.05 REMODULIN 5MG/ML INJ 20ML VIAL, QTY 1 @ $6,206.63 AUGUST FY25
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC CARSWELL |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | Q517 — Pharmacy Services |
| Parent award / vehicle | 36F79720D0104 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $49.8K |
| Current contract value | $49.8K |
| Potential contract value / ceiling | $49.8K |
| Start date | Aug 15, 2025 |
| Current end date | Aug 22, 2025 |
| Potential end date | Aug 22, 2025 |
| Latest award activity | Aug 18, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 18, 2025 | P00001 | $6.3K | OPSUMIT 10MG-QTY 4 @ $6,270.03 ADEMPAS 1MG, QTY 1 @ $12,153.05 REMODULIN 5MG/ML INJ 20ML VIAL, QTY 1 @ $6,206.63 AUGUST FY25 |
| Jul 29, 2025 | 0 | $43.4K | OPSUMIT 10MG-QTY 4 @ $6,270.03 ADEMPAS 1MG, QTY 1 @ $12,153.05 REMODULIN 5MG/ML INJ 20ML VIAL, QTY 1 @ $6,206.63 AUGUST FY25 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.